Physician profile
Luis A Escobar
NPI 1831185602
$33,215.84
in general payments reported to CMS, 2019-2025
21 companies · $9,074 in 2025
The $9,074 reported for 2025 was more than what 95% of Pain Medicine providers received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $354 · 2020: $1,146 · 2021: $4,790 · 2022: $5,702 · 2023: $3,195 · 2024: $8,956 · 2025: $9,074.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $20K · Travel and Lodging: $814.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $20,410.35 |
| Travel and Lodging | $814.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik Nro, INC. | $18,686.01 | 2023-2025 | Prospera, Biotronik |
| Abbott Laboratories | $9,776.91 | 2019-2024 | Proclaim, Eterna |
| Spinal Simplicity, LLC | $1,866.37 | 2021-2022 | |
| Relievant Medsystems, INC. | $616.99 | 2021-2022 | |
| Stryker Corporation | $537.23 | 2023-2024 | Spinejack, Mild Device Kit |
| Vertos Medical, INC. | $415.36 | 2019-2024 | Mild Device Kit |
| Spr Therapeutics, INC | $356.80 | 2022-2025 | Sprint Pns System |
| Nevro Corp. | $305.73 | 2022-2023 | Senza |
| Nalu Medical, INC. | $179.90 | 2021-2023 | Nalu Neurostimulation System |
| Boston Scientific Corporation | $142.06 | 2020-2025 | Intracept |
| Curonix LLC | $64.30 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abbvie INC. | $55.74 | 2022-2023 | |
| Globus Medical, INC. | $40.39 | 2025 | Senza |
| Medtronic, INC. | $37.15 | 2021-2022 | |
| Bioventus LLC | $23.67 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $23.24 | 2025 | |
| Amgen INC. | $23.23 | 2021 | |
| Si-Bone, INC. | $23.17 | 2024 | |
| Horizon Therapeutics Plc | $16.56 | 2022 | |
| Depuy Synthes Sales INC. | $15.29 | 2025 | Orthovisc |
| Forte Bio-Pharma LLC | $9.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Escobar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.